NCI’s information portal that provides overviews of epidemiology, diagnosis and treatment for all major cancers written both for patients and professionals.
This comprehensive database of clinical trials is a useful tool for tracking competitive development activity as well as determining future enrollment demands by indication and geographic location.
The NCCN provides treatment guidelines for both approved and development stage applications of approved drugs based on expert input.
The National Institute for Health and Clinical Excellence in the UK makes treatment recommendations for newly approved drugs which can provide insights on global reimbursement hurdles.
The SEER website is one-stop shopping for top-line epidemiology data and historical trends for oncology indications.